The expression profile of integrin receptors and osteopontin in thyroid malignancies varies depending on the tumor progression rate and presence of BRAF V600E …
G Chernaya, N Mikhno, T Khabalova, S Svyatchenko… - Surgical oncology, 2018 - Elsevier
Thyroid cancer (TC) is one of the most common malignancy of the human endocrine system.
BRAF V600E mutation is the most frequent genetic alteration of papillary carcinoma, the …
BRAF V600E mutation is the most frequent genetic alteration of papillary carcinoma, the …
Evaluation of ITGA3 as a biomarker of progression and recurrence in papillary thyroid carcinoma
G Zhang, B Li, Y Lin - Frontiers in Oncology, 2022 - frontiersin.org
Objective To investigate the expression of ITGA3 and its association with clinical outcomes
in papillary thyroid carcinoma (PTC). Methods The expression level, association with …
in papillary thyroid carcinoma (PTC). Methods The expression level, association with …